Malaysian Biosimilars Guideline

August 15, 2011 11:19 AM

The Ministry of Health Malaysia through the National Pharmaceutical Control Bureau (NPCB), which was set up in 1985, is the Malaysian authority that assures the quality of medicines in the country.

The NPCB is in charge of ensuring that all pharmaceutical and health products in the Malaysian market are of quality, safe and efficacious, regulated according to relevant legislations and used rationally.

In Malaysia, a biosimilar is defined as ‘a new biological medicinal product’ developed to be similar in terms of quality, safety and efficacy to an already registered, ‘well established medicinal product’.

An abbreviated pathway for biosimilars was established and guidelines for biosimilars were published by the NPCB in July 2008. These guidelines cover all biosimilar products:

The guideline is named “Guidance document and guidelines for registration of biosimilars in Malaysia” and can be accessed from here.

The guidance document applies to biological drugs that contain well-characterised proteins, but does not cover complex biological, such as blood-derived products, vaccines, immunologicals, gene/cell therapy products, etc.

Substitution: Approval of a product through the biosimilar pathway is not an indication that the biosimilar may be automatically substituted in Malaysia.

 

Source: NPCB

Leave a Reply

Twitter ID
(ID only. No links or "@" symbols)


Share an Article?

Writing an article is not only a great way to share your knowledge, but it is also a great way to give back to the community.

We value all our contributors and if you have a website, we will surely give a link back to your site and products.
Wanna contribute?

Suggestions?

Biosimilar News was started for the people who are interested in this rapidly growing business area. So if you have suggestions or feedback on how we can improve, please let us know. If you want to see a specific topic covered, answer to a specific question, or anything else of this sort, just write us. We do our best to keep up!
Make a suggestion now!